Melin Eva O, Svensson Ralph, Thunander Maria, Hillman Magnus, Thulesius Hans O, Landin-Olsson Mona
Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Sweden.
Department of Research and Development, Region Kronoberg, Box 1223, SE-351 12 Växjö, Sweden.
BMC Obes. 2017 Jun 2;4:21. doi: 10.1186/s40608-017-0157-1. eCollection 2017.
Obesity is linked to cardiovascular diseases and increasingly common in type 1 diabetes mellitus (T1DM) since the introduction of intensified insulin therapy. Our main aim was to explore associations between obesity and depression, anxiety, alexithymia and self-image measures and to control for lifestyle variables in a sample of persons with T1DM. Secondary aims were to explore associations between abdominal and general obesity and cardiovascular complications in T1DM.
Cross sectional study of 284 persons with T1DM (age 18-59 years, men 56%), consecutively recruited from one secondary care hospital diabetes clinic in Sweden. Assessments were performed with self-report instruments (Hospital Anxiety and Depression Scale, Toronto Alexithymia Scale-20 items and Structural Analysis of Social Behavior). Anthropometrics and blood samples were collected for this study and supplemented with data from the patients' medical records. Abdominal obesity was defined as waist circumference men/women (meters): ≥1.02/≥0.88, and general obesity as BMI ≥30 kg/m for both genders. Abdominal obesity was chosen in the analyses due to the high association with cardiovascular complications. Different explanatory logistic regression models were elaborated for the associations and calibrated and validated for goodness of fit with the data variables.
The prevalence of abdominal obesity was 49/284 (17%), men/women: 8%/29% ( < 0.001). Abdominal obesity was associated with women (AOR 4.9), physical inactivity (AOR 3.1), alexithymia (AOR 2.6) and age (per year) (AOR 1.04). One of the three alexithymia sub factors, "difficulty identifying feelings" (AOR 3.1), was associated with abdominal obesity. Gender analyses showed that abdominal obesity in men was associated with "difficulty identifying feelings" (AOR 7.7), and in women with use of antidepressants (AOR 4.3) and physical inactivity (AOR 3.6). Cardiovascular complications were associated with abdominal obesity (AOR 5.2).
Alexithymia, particularly the alexithymia subfactor "difficulty identifying feelings", physical inactivity, and women, as well as cardiovascular complications were associated with abdominal obesity. As abdominal obesity is detrimental in diabetes due to its association with cardiovascular complications, our results suggest two risk factor treatment targets: increased emotional awareness and increased physical activity.
自强化胰岛素治疗引入以来,肥胖与心血管疾病相关,且在1型糖尿病(T1DM)中越来越常见。我们的主要目的是探讨肥胖与抑郁、焦虑、述情障碍和自我形象测量之间的关联,并在一组T1DM患者样本中控制生活方式变量。次要目的是探讨腹部肥胖和全身肥胖与T1DM心血管并发症之间的关联。
对284例T1DM患者(年龄18 - 59岁,男性占56%)进行横断面研究,这些患者是从瑞典一家二级护理医院糖尿病诊所连续招募的。使用自我报告工具(医院焦虑抑郁量表、多伦多述情障碍量表 - 20项和社会行为结构分析)进行评估。为该研究采集人体测量数据和血液样本,并补充患者病历数据。腹部肥胖定义为男性/女性腰围(米):≥1.02/≥0.88,全身肥胖定义为男女BMI均≥30 kg/m²。由于与心血管并发症高度相关,在分析中选择腹部肥胖。针对这些关联构建了不同的解释性逻辑回归模型,并对其进行校准和验证以符合数据变量的拟合优度。
腹部肥胖的患病率为49/284(17%),男性/女性:8%/29%(P < 0.001)。腹部肥胖与女性(优势比4.9)、身体活动不足(优势比3.1)、述情障碍(优势比2.6)和年龄(每年)(优势比1.04)相关。述情障碍的三个子因素之一,“难以识别情感”(优势比3.1),与腹部肥胖相关。性别分析表明,男性腹部肥胖与“难以识别情感”(优势比7.7)相关,女性腹部肥胖与使用抗抑郁药(优势比4.3)和身体活动不足(优势比3.6)相关。心血管并发症与腹部肥胖相关(优势比5.2)。
述情障碍,特别是述情障碍子因素“难以识别情感”、身体活动不足、女性以及心血管并发症与腹部肥胖相关。由于腹部肥胖因其与心血管并发症的关联而对糖尿病有害,我们的结果提示了两个危险因素治疗靶点:提高情绪意识和增加身体活动。